Product logins

Find logins to all Clarivate products below.


Neurostimulation Devices | Market Insights | Europe | 2021

The European neurostimulation device market is growing modestly, and will be buoyed over the forecast period by the ongoing launch of premium-priced products. Nevertheless, the COVID-19 pandemic will limit growth in the initial years of the forecast period.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for neurostimulation devices in France, Germany, Italy, Spain and the UK across a 10-year period.

Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – Europe
The Europe biosurgical agent market will exhibit modest growth over the forecast period. This expansion will be fueled by a continued preference for biosurgical agents over alternative solutions,…
Report
Trauma Devices – Market Insights – Europe
Although financial constraints among European healthcare facilities and the rise of GPOs that will exert downward pressure on ASPs will limit the European trauma device market, favorable…
Report
Neurostimulation Devices – Market Insights – United States
The US neurostimulation device market will be driven by strategic acquisitions, rapid adoption of novel technologies and increasing availability of advanced products, and new approvals and device…
Report
Infusion Pumps – Market Insights – Europe
The European infusion pump demand will be underpinned by aging populations and rising chronic disease, while accelerating adoption of closed-loop, EHR-integrated smart pumps and growing demand of…
Report
Laparoscopic Devices – Market Insights – Europe
Laparoscopic procedure volumes in Europe will grow only modestly through 2034, with notable variation across procedure types. Bariatric and colorectal laparoscopic surgeries are expected to…